Avedro, Inc Common Stock
AVDR
AVDR was delisted on the 20th of November, 2019.
42 hedge funds and large institutions have $138M invested in Avedro, Inc Common Stock in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$53M |
| 2 |
IVM
InterWest Venture Management
San Francisco,
California
|
+$34.3M |
| 3 |
Jennison Associates
New York
|
+$11.3M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$9.38M |
| 5 |
A
Abingworth
London,
United Kingdom
|
+$9M |
Top Sellers
AVDR Hedge Fund Activity: Q1 2019 in Review
42 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Avedro, Inc Common Stock (AVDR) for Q1 2019, worth a combined $138M.
Buyers outnumbered sellers: 42 funds opened new AVDR positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $53M.
- 42 institutional investors held Avedro, Inc Common Stock (AVDR) as of Q1 2019, up from 0 in Q4 2018.
- Funds reported $138M of Avedro, Inc Common Stock stock for Q1 2019.
- 42 funds opened new Avedro, Inc Common Stock positions in Q1 2019 and 0 closed out, a net change of +42 holders.
- The largest Avedro, Inc Common Stock buyer in Q1 2019 was OrbiMed, an estimated $53M added.
Based on aggregated 13F filings for Q1 2019.